Singapore-based VisVires New Protein (VVNP) has co-led an undisclosed Series A round for Dutch poultry startup In Ovo. The other lead investor is Evonik, a global specialty chemicals company.
According to a statement, the full financing round comes up to “several million dollars”. Investors in the round also include Leiden University, which In Ovo had spun out of.